Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.
- DOI
- 10.1182/bloodadvances.2026020668
- Published
- 2026 Sep 8
- Container
- Blood advances
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1182/bloodadvances.2026020668,
title = {Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.},
author = {Xiao A and Zanwar S and Lin Y and Kapoor P and Abdallah N and Buadi FK and Binder M and Dispenzieri A and Dingli D and Gertz MA and Gonsalves W and Hayman SR and Kourelis T and Leung N and Muchtar E and Siddiqui M and Tan M and Warsame R and Rajkumar SV and Kumar S},
year = {2026},
journal = {Blood advances},
doi = {10.1182/bloodadvances.2026020668},
url = {https://doi.org/10.1182/bloodadvances.2026020668}
}RIS
TY - JOUR TI - Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement. AU - Xiao A AU - Zanwar S AU - Lin Y AU - Kapoor P AU - Abdallah N AU - Buadi FK AU - Binder M AU - Dispenzieri A AU - Dingli D AU - Gertz MA AU - Gonsalves W AU - Hayman SR AU - Kourelis T AU - Leung N AU - Muchtar E AU - Siddiqui M AU - Tan M AU - Warsame R AU - Rajkumar SV AU - Kumar S PY - 2026 JO - Blood advances DO - 10.1182/bloodadvances.2026020668 UR - https://doi.org/10.1182/bloodadvances.2026020668 ER -
APA
A, X., S, Z., Y, L., P, K., N, A., FK, B., M, B., A, D., D, D., MA, G., W, G., SR, H., T, K., N, L., E, M., M, S., M, T., R, W., SV, R., & S, K. (2026). Clinical course, risk factors, and therapeutic response in multiple myeloma with central nervous system involvement.. Blood advances. https://doi.org/10.1182/bloodadvances.2026020668
Source records
- pubmed · retrieved 2026-09-26T00:21:00.907Z